Testing a new heart device for heart failure
Part of Genetic & congenital, Heart & circulation clinical trials.
This trial tests a new device that delivers a gentle electrical current to the heart to improve its pumping strength. It is for people with a certain type of heart failure caused by weak heart muscle, not a blocked artery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have heart failure with reduced pumping strength despite taking the right medicines for at least 3 months.
- Your heart's pumping ability (ejection fraction) is between 25% and 35%, or between 40% and 50%, based on a special scan.
- You are between 18 and 75 years old.
- You have had heart failure symptoms for at least 1 year but less than 5 years.
- You can walk without help for 6 minutes.
- You do not have a pacemaker, defibrillator, or similar device already implanted.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how tiny blood vessels in the heart affect improvement in heart pumping strength for people with heart failure. It tests whether a special procedure during heart catheterization can predict recovery.
This trial tests whether heart muscle cells made from stem cells, injected into the heart, can improve heart function in people with heart failure and a weak heart pump. It may be an option for those who are not getting enough help from other treatments.
This trial studies a small implant (an “atrial shunt” device) to improve symptoms and heart function in people with chronic left heart failure that stays active despite standard medicines. It focuses on whether the implant is safe and can help you feel better and possibly breathe easier.
This trial tests a left ventricular assist system (a mechanical heart pump for the left side of the heart) in people with very severe heart failure. It may help people who are too sick or not improving despite best available medical treatment.
This study tests whether a CardioPulmonary Management (CPM) system device used at home is safe and can improve outcomes for people with chronic heart failure. It may help manage symptoms and reduce complications, especially for higher-risk patients.
This study tests a therapy called Cardiac Contractility Modulation (CCM) for people with heart failure. It uses a device to help the heart pump more strongly, and researchers compare it to standard care using patient records.
Hear when a new Left Ventricular (LV) Systolic Dysfunction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.